(+) -Cevimeline hydrochloride hemihydrate

(+) -Cevimeline hydrochloride hemihydrate is a potent muscarinic agonist researched for xerostomia treatment in Sjögren's syndrome. Its pharmacokinetics and metabolism, involving CYP and FMO enzymes, have been characterized in animal models and in vitro systems, showing species-specific metabolic pathways.